Results 1 to 10 of about 161 (113)

Clinical case: the experience of using acetylsalicylic acid, fosinopril and diltiazem in the therapy of a patient with cardiovascular pathology [PDF]

КардиоСоматика, 2018
The article briefly describes the inhibitor of angiotensin converting enzyme (ACEI) - fosinopril, calcium channel blocker - diltiazem and antiplatelet agent- acetylsalicylic acid (ASA).
V. S Zadionchenko, G. G Shekhyan, A. A Yalymov, A. M Shchikota, S. A Terpigorev, T. G Kabanova, A. M Nikishenkov   +6 more
doaj   +1 more source

EFFECTS OF AMLODIPINE, FOSINOPRIL AND METOPROLOL ON HEMODYNAMICS IN HYPERTENSIVE PATIENTS

Рациональная фармакотерапия в кардиологии, 2015
Aim. To assess an efficacy of antihypertensive therapy with calcium antagonist, angiotensin converting enzyme inhibitor and β-blocker in patients with arterial hypertension (AH) taking into account influence on central and peripheral hemodynamics ...
A. L. Hohlov, M. I. Shunikova, A. Yu. Sosnin, I. N. Kagramanyan, L. A. Lisenkova   +4 more
doaj   +3 more sources

Efficacy of fosinopril and amlodipine in pediatric primary hypertension: a single-center observational study

Frontiers in Pediatrics, 2023
ObjectiveFosinopril and amlodipine are commonly prescribed as first-line pharmacotherapeutic agents for pediatric hypertension, but there is a lack of comparative studies regarding the efficacy of these two drugs.
Hui Wang, Lin Shi, Lin Shi, Yao Lin, Yuting Wang, Wenquan Niu, Yaqi Li   +6 more
doaj   +1 more source

Hyperkalemia in hypertensive patients undergoing regular hemodialysis during enalapril and fosinopril therapy [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2006
Introduction. Hypertension is evident in 80%-85% of patients with chronic renal failure and antihypertensive therapy is needed in 25%-30% of patients. Apart from antihypertensive effect, ACEi’s decrease the left ventricular hypertrophy and mortality in ...
Dimković Nada, Đorđević Tanja, Popović Jovan, Dimković Siniša, Tirmenštajn-Janković Biserka, Živanović Milenko, Žikić Svetlana, Bobanović-Hasković Jasminka   +7 more
doaj   +1 more source

Plasma Fibroblast Growth Factor 23 as a Predictor for Fosinopril Therapeutic Efficacy in Pediatric Primary Hypertension

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Plasma fibroblast growth factor 23 (FGF23) has been reported to be a predictive biomarker for therapeutic effectiveness of angiotensin‐converting enzyme inhibitors in heart failure.
Yao Lin, Yaxi Cui, Yue Yuan, Lu Gao, Qirui Li, Xiaolan Huang, Yanyan Liu, Lin Shi   +7 more
doaj   +1 more source

ACE inhibitor fosinopril in the treatment of hypertension: potential benefits

Медицинский совет, 2014
Fosinopril with dual clearance can be used in renal failure without dose correction, which may be required in diabetes or elderly patients even with normal creatinine level in blood plasma.
AO Konradi
doaj   +1 more source

POSTMENOPAUSAL METABOLIC SYNDROME: CORRECTION OF AUTONOMIC NERVOUS SYSTEM DISBALANCE WITH COMBINATION OF ACE-INHIBITOR AND STATIN

Рациональная фармакотерапия в кардиологии, 2016
Aim. To study dynamics of the indices of heart rate variability (HRV) and heart remodeling in response on combined therapy with fosinopril and simvastatin in postmenopausal metabolic syndrome (MS). Material and methods. 95 women were dynamically examined
I. V. Logacheva, E. N. Shustova, E. V. Kulinich   +2 more
doaj   +1 more source

COMPARISON OF ACE INHIBITOR (FOSINOPRIL) AND Β-ADRENOBLOCKER (ATENOLOL) EFFECTS ON AUTONOMIC REGULATION OF THE HEART IN PATIENTS WITH ARTERIAL HYPERTENSION

Рациональная фармакотерапия в кардиологии, 2016
Aim. To estimate effects of fosinopril and atenolol on autonomic regulation of heart in patients with arterial hypertension (HT) on the basis of spectral characteristics of heart rate variability (HRV).Material and methods.
A. R. Kiselyov, V. I. Gridnev, O. V. Shevchenko, O. M. Posnenkova, A. N. Strunina, V. A. Schwarz, Ja. P. Dovgalevsky   +6 more
doaj   +1 more source

The comorbid patients with arterial hypertension, chronic heart failure and chronic kidney disease: the role of fosinoprile

Медицинский совет, 2018
This article discusses clinicopharmacological niches of fosinopril, one of the most popular ACE inhibitors in daily outpatient practice. The authors cover aspects, where fosinopril has advantages over other ACE inhibitors and angiotensin II receptor ...
G. N. Gorokhovskaya, A. S. Skotnikov, V. L. Yun   +2 more
doaj   +1 more source

COMPARISON OF FOSINOPRIL AND ATENOLOL EFFECT ON HEART 0.1 HZ-RHYTHMS SYNCHRONIZATION AND BLOOD MICROCIRCULATION IN PATIENTS WITH ARTERIAL HYPERTENSION

Рациональная фармакотерапия в кардиологии, 2016
Aim. To compare the effect of fosinopril and atenolol on synchronization of heart 0.1 Hz-rhythms and blood microcirculatory.Material and methods. 63 patients at the age of 47±8 with hypertension (HT) of grade 1-2 were enrolled in the study.
A. R. Kiselev, V. I. Gridnev, A. S. Karavaev, O. M. Posnenkova, V. I. Ponomarenko, M. D. Prochorov, B. P. Bezruchko   +6 more
doaj   +1 more source